New Zealand markets close in 2 hours 41 minutes

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.4400-0.1300 (-5.06%)
At close: 04:00PM EDT
2.4900 +0.05 (+2.05%)
After hours: 04:13PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 576.60M
Enterprise value 124.71M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.03
Price/book (mrq)0.90
Enterprise value/revenue 2.91
Enterprise value/EBITDA -0.45

Trading information

Stock price history

Beta (5Y monthly) 2.51
52-week change 3-69.50%
S&P500 52-week change 321.23%
52-week high 312.3600
52-week low 32.4400
50-day moving average 33.1893
200-day moving average 35.7073

Share statistics

Avg vol (3-month) 3783.87k
Avg vol (10-day) 3647.01k
Shares outstanding 5223.92M
Implied shares outstanding 6223.92M
Float 8118.65M
% held by insiders 145.43%
% held by institutions 123.80%
Shares short (28 Mar 2024) 45.01M
Short ratio (28 Mar 2024) 46.8
Short % of float (28 Mar 2024) 412.62%
Short % of shares outstanding (28 Mar 2024) 42.24%
Shares short (prior month 29 Feb 2024) 44.39M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-332.92%

Management effectiveness

Return on assets (ttm)-18.03%
Return on equity (ttm)-49.26%

Income statement

Revenue (ttm)42.88M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)47.00%
Gross profit (ttm)N/A
EBITDA -242.09M
Net income avi to common (ttm)-302.3M
Diluted EPS (ttm)-1.5600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)464.14M
Total cash per share (mrq)2.07
Total debt (mrq)42.11M
Total debt/equity (mrq)6.99%
Current ratio (mrq)3.56
Book value per share (mrq)2.69

Cash flow statement

Operating cash flow (ttm)-273.37M
Levered free cash flow (ttm)-211.2M